Applications of monoclonal antibodies in clinical oncology.
Application of monoclonal antibodies (mAbs) to clinical settings has proved to be slower than originally hoped. However, a recent conference provided evidence that the field is coming of age, and that antibodies, and their recombinant derivatives, will continue to find a role in the clinic.
George
A J
AJ
Dept of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Spooner
R A
RA
Epenetos
A A
AA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins